Palisade Bio (PALI)
(Delayed Data from NSDQ)
$3.58 USD
-0.01 (-0.28%)
Updated Sep 9, 2024 03:58 PM ET
After-Market: $3.59 +0.01 (0.28%) 5:46 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Cash flow Statements
Fiscal Year End for Palisade Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -12.30 | -14.26 | -26.62 | -16.27 | -8.35 |
Depreciation/Amortization & Depletion | 0.00 | 0.00 | 0.00 | 0.09 | 0.14 |
Net Change from Assets/Liabilities | 0.40 | 1.25 | -4.76 | 0.95 | 0.21 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 0.76 | -0.35 | 16.60 | 6.20 | 0.74 |
Net Cash From Operating Activities | -11.13 | -13.36 | -14.77 | -9.03 | -7.26 |
Property & Equipment | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 3.28 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | -3.33 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | -0.01 | -0.05 | 0.00 | 0.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 12.19 | 16.68 | 25.01 | 14.70 | 6.55 |
Issuance (Repayment) of Debt | -0.39 | -0.79 | -0.18 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | -0.23 | 0.04 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.62 | -0.63 | -0.22 | 0.00 | 0.00 |
Net Cash from Financing Activities | 11.19 | 15.26 | 24.61 | 14.47 | 6.59 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
Net Change In Cash & Equivalents | 0.05 | 1.89 | 9.78 | 5.44 | -0.67 |
Cash at Beginning of Period | 12.41 | 10.52 | 0.74 | 5.11 | 5.79 |
Cash at End of Period | 12.46 | 12.41 | 10.52 | 10.55 | 5.11 |
Diluted Net EPS | -26.99 | -247.83 | -2,541.23 | -5,261.32 | NA |
Fiscal Year End for Palisade Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -7.61 | -3.53 | -12.30 | -9.33 | -5.73 |
Depreciation/Amortization & Depletion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change from Assets/Liabilities | 0.31 | 0.20 | 0.40 | 0.27 | -0.12 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 0.62 | 0.15 | 0.76 | 0.67 | 0.12 |
Net Cash From Operating Activities | -6.68 | -3.18 | -11.13 | -8.39 | -5.73 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 6.51 | 2.50 | 12.19 | 12.18 | 10.44 |
Issuance (Repayment) of Debt | -0.16 | -0.16 | -0.39 | -0.29 | -0.14 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.76 | -0.32 | -0.62 | -0.57 | -0.55 |
Net Cash from Financing Activities | 5.60 | 2.02 | 11.19 | 11.32 | 9.75 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -1.08 | -1.16 | 0.05 | 2.93 | 4.02 |
Cash at Beginning of Period | 12.46 | 12.46 | 12.41 | 12.41 | 12.41 |
Cash at End of Period | 11.38 | 11.30 | 12.46 | 15.34 | 16.43 |
Diluted Net EPS | -3.32 | -4.59 | -3.60 | -7.35 | -7.95 |